Delivery Order SPE2DB22D2007-SPE2DB25FJ2QD

Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of UBRELVY 100 MG TABLET UD 10S, a prescription medication. The contract has a firm fixed price of $2,007.95 and a performance period extending through June 23, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 16S, with a ceiling value of $1,574.22 and a performance period through June 26, 2025. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,703.66, is for the delivery of UBRELVY 100 MG TABLET UD 16S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a prescription medication, with a ceiling value of $2,816.36 and a period of performance through May 8, 2025. This is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a prescription medication. The contract has a firm fixed price, with a ceiling value of $4,204.01 and a completion date of May 13, 2025. This delivery order is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,146.60 and a period of performance through May 16, 2025. The contract is not set aside and was openly competed. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 10S. The contract has a firm fixed price of $6,478.56 and a completion date of June 10, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen Drug Corp and DLA Troop Support Medical, valued at $999,999,999.00. The IDC provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,751.84, is for the delivery of UBRELVY 100 MG TABLET UD 16S, a prescription medication. The contract has a firm fixed price pricing type and a completion date of May 30, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 10S. The contract has a ceiling value of $3,256.08 and a completion date of May 20, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a prescription medication. The contract has a firm fixed price, with a ceiling value of $1,719.90 and a period of performance ending on June 18, 2025. This contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ2QD
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a prescription medication. The contract has a firm fixed price of $14,667.36 and a completion date of June 30, 2025. The contract is not set aside for any specific business type.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC serves as a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/26/25, 9:46 AM